Company Filing History:
Years Active: 2007
Title: Harmut Selle: Innovator in Dementia Detection
Introduction
Harmut Selle is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of progressive chronic dementia diseases. His innovative work has the potential to improve the lives of many patients suffering from such conditions.
Latest Patents
Harmut Selle holds a patent for a "Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents." This invention relates to defined peptides and their quantitative determination in the body fluids of patients suffering from progressive chronic dementia. The inventive peptides are derived from a protein precursor and are processed in a specific manner, with possible post-translational modifications. An increase in the concentrations of these peptides indicates the presence of progressive chronic dementia. This method can be used to control the course of the disease and develop therapeutic agents, particularly for conditions like Alzheimer's disease.
Career Highlights
Harmut Selle is associated with Biovision AG, where he applies his expertise in medical research and diagnostics. His work has garnered attention for its innovative approach to understanding and diagnosing dementia-related diseases. With a focus on practical applications, Selle's contributions are paving the way for advancements in medical technology.
Collaborations
Harmut Selle has collaborated with notable colleagues, including Norbert Lamping and Hans-Dieter Zucht. These partnerships have enhanced the research and development of diagnostic methods in the field of dementia.
Conclusion
Harmut Selle's work in the detection of progressive chronic dementia diseases exemplifies the impact of innovation in medical science. His patented methods and collaborations highlight the importance of research in improving patient outcomes. The advancements made by Selle and his team are crucial in the ongoing fight against dementia-related conditions.